|
Name |
Oleamide
|
Molecular Formula | C18H35NO | |
IUPAC Name* |
(Z)-octadec-9-enamide
|
|
SMILES |
CCCCCCCC/C=C\CCCCCCCC(=O)N
|
|
InChI |
InChI=1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H2,19,20)/b10-9-
|
|
InChIKey |
FATBGEAMYMYZAF-KTKRTIGZSA-N
|
|
Synonyms |
Oleamide; 301-02-0; Oleic acid amide; Oleylamide; Oleyl amide; (Z)-octadec-9-enamide; Slip-eze; Adogen 73; (9Z)-octadec-9-enamide; Crodamide O; Armoslip CP; Crodamide OR; cis-9,10-Octadecenoamide; 9-Octadecenamide; 9-Octadecenamide, (9Z)-; (Z)-9-OCTADECENAMIDE; 9-Octadecenamide, (Z)-; cis-9-Octadecenamide; ELAIDOYLAMIDE; 9Z-octadecenamide; Armid O; Unislip 1759; 9,10-octadecenoamide; (9Z)-9-Octadecenamide; Kemamide O; Petrac Slip-Eze; Amide O; 14C-labeled oleamide; Diamide O 200; Tocris-0878; 7L25QK8BWO; CHEMBL15927; CHEBI:116314; NSC-26987; (9E)-OCTADEC-9-ENAMIDE; ELD; 9,10-octadecenamide; octadec-9-enamide; trans-9,10-octadecenoamide; HSDB 5560; 9-Octadecenoic acid, amide (cis); SR-01000597434; EINECS 206-103-9; NSC 26987; UNII-7L25QK8BWO; Oleyramide; Aliphatic amide; AI3-36742; CCRIS 9471; Octadecene amide; MFCD00053638; 9(z)-octadecenamide; (9Z)-octadecenamide; Plastic additive 12; Diamid O 200; Diamit O 200; Oleamide, >=99%; (cis)-9-Octadecenoate; OLEAMIDE [INCI]; 9-Octadecenamide, cis-; cis-9,10-Octadecanamide; DSSTox_CID_7137; (cis)-9-Octadecenoic acid; Octadec-9-enoic acid amide; OLEYL AMIDE [HSDB]; (9Z)-9-Octadecenamide #; DSSTox_RID_78321; DSSTox_GSID_27137; SCHEMBL36321; BSPBio_001489; GTPL284; Oleamide, analytical standard; BML2-C10; DTXSID6027137; BDBM23028; (cis)-9-Octadecenoic acid amide; (Z)-Octadec-9-enoic acid amide; HMS1361K11; HMS1791K11; HMS1989K11; HMS3402K11; HMS3411B12; HMS3649L11; HMS3675B12; HY-N2327; NSC26987; OLEAMIDE (OLEIC ACID AMIDE); ZINC8036015; Tox21_200444; LMFA08010004; AKOS016010402; CCG-208731; PLASTIC ADDITIVE 12 [USP-RS]; IDI1_033959; NCGC00024839-01; NCGC00024839-04; NCGC00024839-05; NCGC00024839-06; NCGC00024839-07; NCGC00024839-08; NCGC00257998-01; AS-12260; CAS-301-02-0; CS-0021046; O0107; Q4370; C19670; A820197; SR-01000597434-1; SR-01000597434-2; W-106956; Plastic additive 20, European Pharmacopoeia (EP) Reference Standard; Plastic additive 12, United States Pharmacopeia (USP) Reference Standard
|
|
CAS | 301-02-0 | |
PubChem CID | 5283387 | |
ChEMBL ID | CHEMBL15927 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 281.5 | ALogp: | 6.6 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 43.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 20 | QED Weighted: | 0.303 |
Caco-2 Permeability: | -4.947 | MDCK Permeability: | 0.00003340 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.968 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.367 | Plasma Protein Binding (PPB): | 98.30% |
Volume Distribution (VD): | 1.665 | Fu: | 1.03% |
CYP1A2-inhibitor: | 0.304 | CYP1A2-substrate: | 0.234 |
CYP2C19-inhibitor: | 0.373 | CYP2C19-substrate: | 0.058 |
CYP2C9-inhibitor: | 0.214 | CYP2C9-substrate: | 0.906 |
CYP2D6-inhibitor: | 0.162 | CYP2D6-substrate: | 0.492 |
CYP3A4-inhibitor: | 0.421 | CYP3A4-substrate: | 0.047 |
Clearance (CL): | 4.775 | Half-life (T1/2): | 0.413 |
hERG Blockers: | 0.393 | Human Hepatotoxicity (H-HT): | 0.05 |
Drug-inuced Liver Injury (DILI): | 0.026 | AMES Toxicity: | 0.02 |
Rat Oral Acute Toxicity: | 0.022 | Maximum Recommended Daily Dose: | 0.022 |
Skin Sensitization: | 0.947 | Carcinogencity: | 0.067 |
Eye Corrosion: | 0.029 | Eye Irritation: | 0.679 |
Respiratory Toxicity: | 0.184 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001646 | 1.000 | D0O1PH | 0.757 | ||||
ENC002845 | 0.895 | D0O1TC | 0.538 | ||||
ENC001555 | 0.839 | D07ILQ | 0.519 | ||||
ENC001699 | 0.839 | D0OR6A | 0.468 | ||||
ENC001419 | 0.839 | D0UE9X | 0.462 | ||||
ENC001100 | 0.839 | D0Z5SM | 0.461 | ||||
ENC001592 | 0.839 | D05ATI | 0.444 | ||||
ENC001591 | 0.839 | D00AOJ | 0.393 | ||||
ENC001710 | 0.826 | D0Z5BC | 0.388 | ||||
ENC001682 | 0.800 | D09SRR | 0.375 |